UBS reiterates Nasdaq stock rating citing strong equity volumes By Investing.com

UBS reiterated Buy on Nasdaq with a $120 price target, citing strong solutions and FinTech growth, with Q1 2026 EPS held at $0.92 versus $0.93 consensus and full-year 2026 EPS forecast at $3.90. Nasdaq also raised its medium-term solutions revenue growth outlook to 9-12% from 8-11% while maintaining 5-8% expense growth guidance. The company is expanding into tokenized equities and digital asset infrastructure, reinforcing its fintech and innovation strategy.

Analysis

The key incremental setup is not the headline growth revision itself, but the widening quality gap inside the exchange/market data complex. If core listing and trading are merely stable while solutions and fintech accelerate, NDAQ’s mix shifts toward higher-multiple, recurring revenue streams that deserve a valuation rerate relative to pure transaction-volume peers; that makes this more of a margin durability story than a cyclical volume story.

Second-order beneficiaries are the ecosystem vendors tied to data, workflow, and surveillance rather than the exchanges alone. As tokenization and digital-asset plumbing move from experimentation to production, the likely winners are incumbents that can sell compliance and post-trade infrastructure into regulated workflows; that is structurally favorable for adjacent software and market infrastructure names, while putting pressure on smaller point-solution fintechs that lack distribution and regulatory trust.

The main near-term risk is that investors may already be front-running the “solutions mix shift,” leaving limited upside into earnings unless the company prints a clean beat on ARR and expense discipline. Over the next 1-3 months, the stock can still de-rate if market services revenue decelerates or if options/cash equities volumes normalize after a strong period; over 12-24 months, the bigger risk is that digital-asset monetization remains narrative-heavy and revenue-light.

Consensus appears to be underestimating how much of the upside is coming from operating leverage, not just revenue growth. If management sustains the higher medium-term growth guide without reaccelerating opex, the real bull case is a multiple expansion from a steadier recurring-revenue profile; if not, the stock likely stays rangebound near fair value and the better expression is relative value rather than outright beta exposure.

Key Decisions for Investors

• Go long NDAQ into earnings with a 2-6 week horizon; prefer call spreads over stock to capture a potential guide/takeout of consensus while limiting downside if volumes disappoint.
• Pair trade: long NDAQ / short a lower-quality exchange or transaction-heavy market infrastructure name over the next 1-3 months to isolate the mix-shift and recurring-revenue re-rating versus pure volume exposure.
• Add a small tactical long in regulated market-data / compliance infrastructure beneficiaries for a 3-12 month horizon; the tokenization and surveillance partnerships create a higher-probability monetization path there than in speculative digital-asset names.
• If NDAQ rallies meaningfully into earnings without a beat, fade strength with a short-dated call overwrite or partial profit-taking; upside beyond fair value likely requires evidence that solutions growth is translating into margin expansion.
• Avoid chasing broad fintech beta here; the cleaner trade is to own incumbents with distribution and regulatory trust rather than early-stage tokenization or crypto infrastructure names that may not convert headlines into revenue.